• About us
• Contact

Advertisement

Collaboration › Details

Agilent–JPMorgan Chase: investor conference, 202101 supply service Agilent presents at JP Morgan Healthcare Conference 2021

 

	Period	2021-01-12
	Partner, 1st	Agilent Technologies Inc. (NYSE: A)
	Partner, 2nd	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 39th Annual Healthcare Conference 2021 DIGITAL
	Product 2	analytical instrument
	Person	McMullen, Mike (Agilent 201409– COO + designated CEO for 3/15 before SVP + President Chemical Analysis Group)

Agilent Technologies Inc.. (12/16/20). "Press Release: Agilent Announces Webcasts for Investment Community". Santa Clara, CA.

Agilent Technologies Inc. (NYSE: A) today announced dates and times of two upcoming webcasts for the investment community.

Goldman Sachs Healthcare CEOs Unscripted Conference
Tuesday, Jan. 5, 2021 at 2:25 p.m. Eastern/11:25 a.m. Pacific
Presenter: Mike McMullen, Agilent president and CEO

39th Annual J.P. Morgan Healthcare Conference
Tuesday, Jan. 12, 2021 at 11:40 a.m. Eastern/8:40 a.m. Pacific
Presenter: Mike McMullen, Agilent president and CEO

When they become available, links to join the webcast may be found in the “News & Events – Events” section of the Investor Relations portion of the Agilent website.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom.

Follow Agilent on LinkedIn, Twitter, and Facebook.

Record changed: 2020-12-19

Advertisement

More documents for Agilent (Group)

• [1] Agilent Technologies Inc.. (2/21/24). "Press Release: Agilent CEO Mike McMullen to Retire Agilent CrossLab Group – President Padraig McDonnell Named CEO-Elect". Santa Clara, CA....
• [2] Agilent Technologies Inc.. (12/20/23). "Press Release: Agilent Makes Strategic Updates to Organizational Structure". Santa Clara, CA....
• [3] Agilent Technologies Inc.. (12/18/23). "Press Release: Agilent to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Santa Clara, CA....
• [4] Agilent Technologies Inc.. (9/12/23). "Press Release: Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience". Santa Clara, CA & Madison, WI....
• [5] Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA....
• [6] Agilent Technologies Inc.. (9/5/23). "Press Release: Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group". Santa Clara, CA....
• [7] Agilent Technologies Inc.. (9/4/23). "Press Release: Agilent and ACTRIS Partner to Accelerate Cell and Gene Therapy in Singapore". Singapore....
• [8] Agilent Technologies Inc.. (8/3/23). "Press Release: Agilent Announces Thought Leader Award to Peter Neubauer". Santa Clara, CA....
• [9] Agilent Technologies Inc.. (6/12/23). "Press Release: Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference". Santa Clara, CA....
• [10] Synthego Corporation. (5/17/23). "Press Release: Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute". Redwood City, CA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.